Date: 2-5 April 2019
Venue: Bournemouth International Centre, UK
Tuesday 2 April 2019
BHIVA Pre-conference Meeting: Important Challenges
BHIVA’s position on U=U an update
Dr Nadi Gupta, Rotherham NHS Foundation Trust
U=U in resource limited countries
Mr Bruce Richman, Prevention Access Campaign, USA
U=U the legal context
Prof Matthew Weait, University of Portsmouth
HIV care in immigration detention and removal
Kat Smithson, NAT
Wednesday 3 April 2019
Welcome and Introduction
Welcome and Introduction by Chair of BHIVA
Prof Chloe Orkin, Barts Health NHS Trust, London
Welcome by Local Host
Dr Kate Schroeder, Royal Bournemouth Hospital
BHIVA Review Session
New antiretroviral data
Dr Amanda Clarke, Royal Sussex County Hospital, Brighton
New hepatitis data: hepatitis C in people with and without HIV, lessons learned from the hepatitis A outbreak
Dr Andrew Ustianowski, North Manchester General Hospital
BHIVA Plenary Session 1
Declining HIV incidence: is it all good news?
Dr Valerie Delpech, Public Health England
Syphilis: what can HIV clinics do?
Dr Iain Reeves, Homerton University Hospital, London
Phylogenetic research: the basics, application to outbreaks, ethical issues & talking to patients
Dr Larissa Mulka, Brighton and Sussex Medical School
BHIVA Invited Lecture 1
Autopsies: lessons learned and legal requirements
Prof Sebastian Lucas, St Thomas’ Hospital
BHIVA Lunchtime Workshop 1 - Clinico-pathological case presentations
Thinking outside the Sepsis Six box
Dr Beatrice Cockbain, Barts Health
A weight off my shoulder
Dr Toni Masters, Coventry ISHS
Not just Found in Germany!
Dr Hannah Yeend, Central & North West London NHS Foundation Trust
BHIVA Lunchtime Workshop 2
People and Places: Cities Fast- Tracking the HIV response
Mr Bertrand Audoin, IAPAC Fast Track Cities Coordinator, Europe
Panel discussion with representatives from the UK’s Fast Track Cities – Brighton, Glasgow, Liverpool, London, Manchester
BHIVA Invited Lecture 2
The HIV Prevention Cascade
Prof James Hargreaves, London School of Hygiene and Tropical Medicine
Oral Research Presentations: Session 1 (1–6)
Abstract O01 - The impact of the introduction of a specialist HIV pharmacy service (SHPS) to satellite HIV clinics
Naman Vora, Chelsea and Westminster Hospital NHS Foundation Trust
Abstract O02 - Improving communication between Primary and Secondary Care for HIV positive patients
Melanie Rosenvinge, Lewisham and Greenwich NHS Trust
Abstract O03 - Facilitating primary care non-antiretroviral drug prescribing in people living with HIV: the Think ARV project
Heather Leake Date, Brighton and Sussex University Hospitals NHS Trust
Abstract O04 - BHIVA guidelines and breastfeeding in the UK: the current picture
Kate Francis, UCL, GOS Institute of Child Health
Abstract O05 - 38% of childbearing women with HIV in the UK would like to breastfeed – PACIFY STUDY
Farai Nyatsanza, Imperial College Healthcare NHS Trust
Abstract O06 - Optimal timing for serological screening for HIV exposed uninfected infants; the later the better?
Avni Hindocha, Imperial College Healthcare NHS Trust
BHIVA Invited Lecture 3
Smoking: are e-cigarettes the solution?
Dr Lion Shahab, University College London
Thursday 4 April 2019
Oral Research Presentations: Session 2 (7–15)
Abstract O07 - The role of Raltegravir alone or combined with Lamivudine as PrEP: a phase 2 randomised controlled clinical trial
Julie Fox, Guys and St Thomas’ NHS Trust
Abstract O08 - Pharmacokinetics (PK) of bictegravir (BIC) in combination with polyvalent cation containing (PVCC) antacids and supplements
Samuel Kabagambe, Gilead Sciences
Abstract O09 - High level of pre-existing NRTI resistance prior to switching to B/F/TAF (Study 4030)
Leena Sathia, Gilead Sciences
Abstract O10 - Long-active cabotegravir + rilpivirine for HIV maintenance: FLAIR week 48 results
Chloe Orkin, Queen Mary University
Abstract O11 - The impact of vorinostat & therapeutic vaccine on gut HIV DNA – the RIVER gut study
John Thornhill, Imperial College London
Abstract O12 - The effect of time to viral suppression at primary HIV infection on long term immunological recovery: results from the HEATHER cohort
Julianne Lwanga, Guy’s & St. Thomas’ NHS Foundation Trust
Abstract O13 - Discontinuations & virologic response in late presenters with insti -or pi-based art
Jessica Doctor, Guy’s and St Thomas’s Hospital
Abstract O14 - Sustained HIV-1 remission following CCR5Δ32/Δ32 allogeneic haematopoietic stem cell transplantation
Laura Waters, Mortimer Market Centre
Abstract O15 - Safety of tenofovir alafenamide (TAF) in patients with a history of proximal renal tubulopathy on tenofovir disoproxil fumarate (TDF)
Frank Post, King’s College London
BHIVA Plenary Session 2: Keynote Lecture
New Challenges for ART programmes
Dr Angela Obasi, Liverpool School of Tropical Medicine
BHIVA Invited Lecture 4
Surrogate markers of cardiovascular risk: a summary and what it all means
Dr Michael Emerson, Imperial College London
BHIVA Lunchtime Workshop 3
Ageing and HIV: who should co- ordinate care?
Dr Tom Levett, Brighton and Sussex University Hospitals NHS Trust
BHIVA/UKCAB Lunchtime Workshop 4
Can the drop in new HIV diagnoses in London’s MSM population be extended to the rest of the UK and to wider demographics?
Ms Winnie Sseruma, Freelance International Development Consultant
Ms Bakita Kasadha, CHIVA
Mr Eli Fitzgerald, CHIVA
Ms Samantha Dawson, Body Positive Dorset
Oral Research Presentations: Session 3 (16–24)
Abstract O16 - IV antiretroviral drug regimens and lung function decline in early HIV infection
Ken Kunisaki, Minneapolis VA Health Care System
Abstract O17 - Invasive pneumococcal disease in people living with HIV in England, 1999-2017
Peter Kirwan, Public Health England
Abstract O18 - Equivalent responses to quadrivalent influenza vaccine are detectable in blood and oral fluid in healthcare workers and men living with HIV on ART
Katrina Pollock, Imperial College London
Abstract O19 - HIV co-morbidities and their impact on attendance frequency at HIV clinics in England and Wales: findings from Positive Voices 2017 linked to national cohort data
Peter Kirwan, Public Health England
Abstract O20 - Self-reported symptoms of insomnia and objective measures of sleep quality in people living with HIV and comparable controls
Davide De Francesco, University College London
Abstract O21 - Psychological burden and the impact on engagement with care among ethnically diverse older women with HIV
Rageshri Dhairyawan, Barking, Havering and Redbridge NHS Trust
Abstract O22 - Clinical outcomes and experiences of trans people accessing HIV care in England
Peter Kirwan, Public Health England
Abstract O23 - Risk factors and patterns of HCV transmission amongst men who have sex with men
Daniel Bradshaw, Public Health England
Abstract O24 - Fall in HCV incidence in HIV+ MSM in London following expansion of access to DAA therapy
Lucy Garvey, Imperial College Healthcare NHS Trust
BHIVA Invited Lecture 5
Interactive cases: rashes from the tropics
Dr Claire Fuller, Chelsea & Westminster Hospital
Friday 5 April 2019
BHIVA Audit Session
Pilot results from late HIV diagnosis review process
Dr Ming Lee, Guy’s and St Thomas’ NHS Foundation Trust, London
Audit & Improvement
Dr Hilary Curtis, BHIVA Audit Coordinator
Oral Research Presentations: Session 4 (25–30)
Abstract O25 - Sexual health education landscape in Scotland
Nathan Sparling, HIV Scotland
Abstract O26 - Reducing barriers to HIV self-testing among black African communities – self- testing pilot. A Public Health England HIV Innovation Project, December 2017- November 2018
George Halfin, Terrence Higgins Trust
Abstract O27 - Attitudes and factors to PrEP uptake among HIV risk groups across London
Renee West, GMI Partnership
Abstract O28 - Happy birthday Scottish PrEP! Uptake and STI epidemiology from the first year of the NHS HIV PrEP programme in Scotland
Nicola Steedman, NHS National Services Scotland
Abstract O29 - U=U: patient and staff awareness, understanding and impact
Naomi Adams, Mortimer Market Centre
Abstract O30 - Molecular characterisation of HIV acquisition events in the PARTNER study
Anna Maria Geretti, University of Liverpool
Oral Research Poster Presentations
BHIVA Lunchtime Workshop 5: Complex PrEP cases - case presentations
Do your PrEP
Dr Emily Chung, Mortimer Market Centre
False positive HIV result
Dr Jasmini Alagaratnam, Imperial College London
PrEP toxicity case
Dr Lakshmi Jain, Mortimer Market Centre
BHIVA Lunchtime Workshop 6
Implementation science: what is it and who can do it?
Dr Tristan Barber, Royal Free London NHS Foundation Trust
Dr Nadine Seward, King’s College London
Prof Jane Anderson, Homerton University Hospital, London
BHIVA Prizes and Awards Ceremony
BHIVA Invited Lecture 6
Immune reconstitution inflammatory syndrome (IRIS)
Dr Sarah Pett, MRC Clinical Trials Unit at UCL
BHIVA Plenary Session 3
Pregnancy and breastfeeding
Dr Catriona Waitt, University of Liverpool
Is rapid ART right for all?
Mr Simon Collins, HIV i-Base
Close
Close by Chair of BHIVA
Prof Chloe Orkin, Barts Health NHS Trust, London